TGA Approval

ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack (318801)

ARTG ID

318801

ARTG Name

ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

July 17, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/b2ca4fc00220d3fa6d872e78c07129cd.pdf

https://medical-cdn.nocode.com/drug_tga/cbf3e4c40a7b85cf63b976e2405227d6.pdf

Ingredient Name

ozanimod hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack (318801) - TGA 批准文号 | MedPath